User menu

Tumor dosimetry based on PET Y-86-DOTA-Tyr3-octreotide (SMT487) and CT-scan predicts tumor response to Y-90-SMT487 (OctreoTher (TM)) therapy.

Bibliographic reference Jonard, P. ; Jamar, François ; Pauwels, Stanislas ; Walrand, Stéphan ; Collart, JP ; et. al. Tumor dosimetry based on PET Y-86-DOTA-Tyr3-octreotide (SMT487) and CT-scan predicts tumor response to Y-90-SMT487 (OctreoTher (TM)) therapy..In: The Journal of Nuclear Medicine, Vol. 41, no. 5, p. 111P-111P (2000)
Permanent URL http://hdl.handle.net/2078.1/62066